Latest News about OTSKY
Recent news which mentions OTSKY
Axsome Reveals Data From Alzheimer's Studies, Analyst Sees Hope Despite Mixed Trial Results
December 31, 2024
From Benzinga
Tickers
OTSKY
From InvestorPlace
Tickers
OTSKY
From InvestorPlace
IGC Pharma Says Cannabinoid-Based Drug Candidate Provides Fast Relief With Fewer Side Effects For Alzheimer's-Associated Agitation
April 16, 2024
From Benzinga
Alzheimer's-Focused Small Cap Firm IGC Pharma Releases Data, Candidate Reduces Agitation Compared To Placebo
March 20, 2024
From Benzinga
Regulatory Setback For Medtronic's High Blood Pressure Device - FDA Backed Japanese Firms' Similar Device For Uncontrolled Hypertension
August 24, 2023
From Benzinga
Individuals With Uncontrolled Hypertension - FDA Adcomm Panel Just Supported Japanese MedTech's Blood Pressure Treatment Device
August 23, 2023
From Benzinga
Japan's Otsuka Pharma-Lundbeck Partnered Depression Drug Gets FDA Approval For Alzheimer's Agitation
May 11, 2023
From Benzinga
From Benzinga
Akebia's Anemia Drug Disappoints In Mid-Stage COVID-19 Study
August 05, 2022
From Benzinga
From Benzinga
Why Are Akebia Therapeutics Shares Falling Today?
May 16, 2022
From Benzinga
From Benzinga
4 Pre-Merger SPACs to Buy That Are Poised to Soar
November 16, 2021
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.